Premium
At a time when most Indian pharmaceutical companies were having a tough time due to challenges from both domestic and overseas markets, Sequoia Capital-backed Sai Life Sciences Ltd, too, went under the weather seeing its revenue growth fall to single digits.While its 2016-17 revenue growth clocked just over 7%, it ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
